Olmesartan Pediatric Pharmacokinetic (PK) Study

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Hypertension
Interventions
DRUG

Olmesartan medoxomil

Children less than 6 years old: oral suspension or tablets equal to 0.3 mg/kg; 20 mg or 40 mg tablets for older children depending on weight.

Trial Locations (5)

Unknown

Little Rock

La Jolla

Louisville

Kansas City

Cleveland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY